Abacavir, dolutegravir, and lamivudine and Siltuximab Intravenous
Determining the interaction of Abacavir, dolutegravir, and lamivudine and Siltuximab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: abacavir / dolutegravir / lamivudine
Brand name: Triumeq
Synonyms: Abacavir, Dolutegravir, and Lamivudine
Generic Name: siltuximab
Brand name: Sylvant
Synonyms: Siltuximab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Abacavir, dolutegravir, and lamivudine-Silvadene
- Abacavir, dolutegravir, and lamivudine-Silvadene Topical
- Abacavir, dolutegravir, and lamivudine-SilvaSorb
- Abacavir, dolutegravir, and lamivudine-Silver
- Abacavir, dolutegravir, and lamivudine-Silver Nitrate
- Abacavir, dolutegravir, and lamivudine-Silver Nitrate Applicators
- Siltuximab Intravenous-Abacavir, Lamivudine and Zidovudine Tablets
- Siltuximab Intravenous-Abacavir, lamivudine, and zidovudine
- Siltuximab Intravenous-Abaloparatide
- Siltuximab Intravenous-Abaloparatide Subcutaneous
- Siltuximab Intravenous-Abatacept
- Siltuximab Intravenous-Abatacept Auto-Injectors